Search

Displaying results 9901 - 9910 of 10000 in total
  1. Drug

    Aloracetam

    go.drugbank.com/drugs/DB21233
    Experimental

    The usage of the INN stem '-racetam' in the name indicates that Aloracetam is a piracetam type amide type nootrope agent. Aloracetam has a monoisotopic molecular weight of 208.12 Da.

  2. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    The usage of the INN stem '-tidine' in the name indicates that Oxmetidine is a histamine- H2​-receptor antagonist, cimetidine derivative. Oxmetidine has a monoisotopic molecular weight of 399.14 Da.

  3. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    The usage of the INN stem '-giline' in the name indicates that Tisolagiline is a monoamine oxydase (MAO)-inhibitor type B. Tisolagiline has a monoisotopic molecular weight of 322.13 Da.

  4. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    The usage of the INN stem '-rafenib' in the name indicates that Mosperafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor. Mosperafenib has a monoisotopic molecular weight of 461.1 Da.

  5. Drug

    Epofolate

    go.drugbank.com/drugs/DB12266
    Investigational

    Epofolate has been used in trials studying the treatment of Advanced Solid Tumors. … In Phase I/IIa pharmacokinetic and safety studies epofolate was generally tolerable and toxicities known to be associated with epothilone class of anticancer agents were common, although peripheral neuropathy

  6. Drug

    AUTO3

    go.drugbank.com/drugs/DB17364
    Investigational

    It is an investigational chimeric antigen receptor (CAR) T cell treatment targeting CD19 and CD22.

  7. Drug

    NP-6A4

    go.drugbank.com/drugs/DB17599
    Experimental

    It has an Orphan Drug designation from the FDA for pediatric cardiomyopathy.[A258523]

  8. Drug

    Emrusolmin

    go.drugbank.com/drugs/DB13927
    Investigational

    Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology.

  9. Drug

    2-chloroethyl-3-sarcosinamide-1-nitrosourea

    go.drugbank.com/drugs/DB11688
    Investigational

    2-chloroethyl-3-sarcosinamide-1-nitrosourea has been used in trials studying the treatment of Colorectal Cancer, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific

  10. Drug

    Nerve Growth Factor

    go.drugbank.com/drugs/DB12620
    Investigational

    Nerve Growth Factor has been used in trials studying the prevention and treatment of Mental Handicap, Alzheimer's Disease, Traumatic Brain Injury, Cerebral Palsy Children, and Delayed Speech Development